IV hydration therapy, also known as intravenous therapy, involves administering fluids such as normal saline, dextrose solutions or electrolyte solutions directly into the bloodstream through an intravenous access device. IV hydration therapy is offered as an effective treatment option for conditions involving fluid loss or electrolyte imbalances in the body such as dehydration, hangovers, food poisoning and gastroenteritis. It helps restore fluid and electrolyte balance in the body faster than oral rehydration. Treatment with IV fluids is also beneficial for elite athletes and individuals engaged in excessive physical activities to prevent dehydration. With rising health awareness, many opt for IV therapy as a preventive health measure or hangover cure. Additionally, increased prevalence of lifestyle diseases like diabetes which can lead to dehydration is contributing towards the growing demand for IV hydration services across Europe.
The global Europe IV Hydration Therapy Market is estimated to be valued at US$ 261.68 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends bolstering growth of the Europe IV hydration therapy market size is rising health consciousness among consumers and focus on preventive healthcare. IV hydration offers a quick solution to treat dehydration and replenish fluids and electrolytes lost without prescription medicines. This is encouraging healthy individuals to opt for IV therapies for hangover treatment or as part of wellness regimes. Additionally, growing popularity of medical tourism in countries like Turkey, Poland and Hungary is positively impacting the regional market. Individuals from other European countries are traveling to these nations for cost effective IV hydration treatments. Overall, increased awareness about health advantages of IV therapy and availability of diverse IV treatment packages catering to different needs present lucrative opportunities for market players in the Europe region.
Threat of new entrants: The threat of new entrants in the Europe IV hydration therapy market is low. Well established players dominate the industry.
Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of alternative products in the market.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as there are many suppliers in the market.
Threat of new substitutes: The threat of substitutes is low as IV hydration therapy solutions have few close substitutes.
Competitive rivalry: The competitive rivalry is high among the key players to gain major market share.
The Europe IV hydration therapy market is expected to witness high growth over the forecast period. The global Europe IV Hydration Therapy Market is estimated to be valued at US$ 261.68 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030.
Regional analysis: The Europe IV hydration therapy market is projected to be led by Germany. Germany contributes the largest market share due to the growing incidences of dehydration. The UK and France are also forecasted to witness significant growth due to increasing awareness about IV therapy.
Key players: Key players operating in the Europe IV hydration therapy market are Hydrx, Hydramed Ltd., Amsino International, B. Braun Melsungen AG. Baxter Healthcare Corporation.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it